Moderna to potentially supply Japan with 40M doses of COVID-19 vaccine

By The Science Advisory Board staff writers

Moderna is in discussion with the Ministry of Health, Labour, and Welfare of Japan (MHLW) to potentially purchase 40 million or more doses of its messenger RNA (mRNA) vaccine candidate against COVID-19 to support Japan's efforts in securing vaccines as soon as possible.

Under the agreement, Moderna would supply mRNA-1273 and Takeda Pharmaceutical Company would distribute it in the first half of 2021, upon successful regulatory approval, said Kato Katsunobu, minister of MHLW, in a meeting on August 28.

Copyright © 2020

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?